Dr. Charles D. Sly, DPharm, MBA
Chief Biotechnology Officer
The RegenerAge® Team has 22+ Years of Combined Experience in Advanced Regenerative Medicine Solutions.
Dr. Charles D. Sly is the Chief Biotechnology Officer of RegenerAge®Elite Clinic. He is also a co-founder and Chief Scientific Officer (CSO) at JC Biotech LLC, a biotechnology firm based in the United States of America.
With an unwavering commitment to advancing scientific knowledge, Dr. Sly has established himself as a preeminent authority in a multitude of specialized disciplines. His profound expertise encompasses the domains of Clinical Pharmacokinetics, Clinical Pharmacy, Biomaterials, Tissue Engineering, and Therapeutic Drug Monitoring. It is through an unparalleled dedication to his craft that Dr. Sly has achieved exceptional levels of proficiency in these areas.
Having undertaken his formative education at the esteemed Roseman University of Health Sciences, College of Pharmacy in the United States, Dr. Sly emerged as a pharmacist with a deep-seated passion for scientific inquiry. Armed with an extensive repertoire of pharmaceutical knowledge, he embarked on a remarkable journey, relentlessly pursuing scientific breakthroughs and pioneering innovations.
Throughout his career, Dr. Sly has harnessed his profound acumen and prodigious talents to revolutionize the biotechnology landscape. His remarkable contributions have primarily centered on the development of cutting-edge solutions, leveraging biotechnology to propel advancements in injury recovery, performance enhancement, and metabolic management. Dr. Sly’s unparalleled expertise and multifaceted skill set have positioned him at the vanguard of this transformative field.
Dr. Sly’s professional trajectory has been punctuated by a multitude of significant accomplishments, affirming his unwavering commitment to scientific excellence. As the Chief Biotechnology Officer at RegenerAge® Elite Clinic, he plays a pivotal role in orchestrating groundbreaking initiatives, spearheading a team of brilliant minds, and facilitating the application of biotechnological advancements in the pursuit of human well-being.
Moreover, Dr. Sly’s position as the co-founder and CSO of JC Biotech LLC bears testament to his entrepreneurial spirit and visionary leadership. Within this pioneering organization, he has harnessed his vast reservoir of knowledge and experience to drive research and development efforts, pushing the boundaries of biotechnology and unlocking new frontiers of scientific innovation.
Dr. Charles D. Sly stands as a paragon of scientific prowess, melding unwavering dedication with unyielding determination to bring about tangible advancements in the realms of biotechnology and pharmaceutical sciences. Through his unrelenting pursuit of excellence, he has solidified his place as a transformative figure within the scientific community, leaving an indelible mark on the fields of injury recovery, performance enhancement, and metabolic management. Dr. Sly’s unparalleled contributions to the biotechnology landscape have forever altered the trajectory of scientific progress, epitomizing the transformative potential that lies at the intersection of human ingenuity and technological innovation.
Expansion into the EU
Addressing the European market with high-end Regenerative Medicine solutions.
Amassed over 48,000 treatments among the group's talented team.
RegenerAge® Clinic was founded
The concept of innovative clinical solutions was born.